Financials
- Market Capitalization 276.65 M
- Employee 106
- Founded 2014
- CEO N/A
- Website www.zentalis.com
- Headquarter California, United States
- FIGI BBG00R2K8TF5
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.71
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3379 | TRDA Entrada Therapeutics, Inc. - Common Stock | 7.18 USD | -1.24% | -5.28% | +24.22% | +3.01% | 279.57 M USD | ||
| 3383 | SRZN Surrozen, Inc. - Common Stock | 23.28 USD | -3.04% | -1.10% | +18.90% | +100.86% | 273.62 M USD | ||
| 3400 | NMRA Neumora Therapeutics, Inc. - Common Stock | 1.49 USD | +0.68% | -7.45% | -11.83% | -14.86% | 279.96 M USD | ||
| 3402 | WHWK Whitehawk Therapeutics, Inc. - Common Stock | 4.87 USD | +0.62% | 0.00% | +32.34% | +61.79% | 277.63 M USD |